These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 8707380)

  • 1. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
    Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
    Li JS; Sventek P; Schiffrin EL
    J Hypertens; 1996 Nov; 14(11):1331-9. PubMed ID: 8934362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension.
    Moreau P; Takase H; Küng CF; Shaw S; Lüscher TF
    Hypertension; 1997 Mar; 29(3):763-9. PubMed ID: 9052893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelin-1 gene expression and effect on blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats.
    Sventek P; Turgeon A; Schiffrin EL
    Circulation; 1997 Jan; 95(1):240-4. PubMed ID: 8994442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
    Li JS; Schürch W; Schiffrin EL
    Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 gene expression in blood vessels and kidney of spontaneously hypertensive rats (SHR), L-NAME-treated SHR, and renovascular hypertensive rats.
    Deng LY; Schiffrin EL
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S380-3. PubMed ID: 9595489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.
    Li JS; Schiffrin EL
    Hypertension; 1995 Apr; 25(4 Pt 1):495-500. PubMed ID: 7721389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
    Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist, and an endothelin receptor antagonist on renal afferent arteriolar structure.
    Skov K; Fenger-Grøn J; Mulvany MJ
    Hypertension; 1996 Sep; 28(3):464-71. PubMed ID: 8794834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats.
    Varagic J; Jerkic M; Jovovic D; Nastic-Miric D; Adanja-Grujic G; Markovic-Lipkovski J; Lackovic V; Radujkovic-Kuburovic G; Kentera D
    Am J Med Sci; 2000 Sep; 320(3):171-6. PubMed ID: 11014370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
    Nakamura Y; Ono H; Zhou X; Frohlich ED
    Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.
    Seo B; Lüscher TF
    Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilazapril reverses endothelium-dependent vasodilator response to acetylcholine in mesenteric artery from spontaneously hypertensive rats.
    Young RH; Ding YA; Lee YM; Yen MH
    Am J Hypertens; 1995 Sep; 8(9):928-33. PubMed ID: 8541009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats.
    Li JS; Schiffrin EL
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):68-74. PubMed ID: 8797138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and hypertension differently affect coronary contractions to endothelin-1, serotonin, and angiotensins.
    Tschudi MR; Lüscher TF
    Circulation; 1995 May; 91(9):2415-22. PubMed ID: 7729029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H; Ono Y; Frohlich ED
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats.
    Vaskonen T; Mervaala E; Krogerus L; Teräväinen TL; Laakso J; Karppanen H; Vapaatalo H
    Hypertens Res; 1997 Sep; 20(3):183-92. PubMed ID: 9328799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.